Tevogen Bio Company Insiders
| TVGNW Stock | 0.04 0.01 10.20% |
Tevogen Bio employs about 12 people. The company is managed by 12 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Recap of Tevogen Bio's management performance can provide insight into the venture performance.
Tevogen |
Tevogen Bio Management Team Effectiveness
Return On Tangible Assets is likely to drop to -0.0041 in 2024. Return On Capital Employed is likely to drop to -0.0007 in 2024. Total Assets is likely to drop to about 16.2 M in 2024. Non Current Assets Total is likely to drop to about 15.8 M in 2024Tevogen Bio's management efficiency ratios could be used to measure how well Tevogen Bio manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to drop to about 148.7 M in 2024
Tevogen Bio Workforce Comparison
Tevogen Bio Holdings is currently under evaluation in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 117,515. Tevogen Bio adds roughly 0.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Tevogen Bio Holdings Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Tevogen Bio Holdings Price Series Summation is a cross summation of Tevogen Bio price series and its benchmark/peer.
Tevogen Bio Notable Stakeholders
A Tevogen Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tevogen Bio often face trade-offs trying to please all of them. Tevogen Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tevogen Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MPH MD | CEO CoFounder | Profile | |
| MD MPH | CEO CoFounder | Profile | |
| Kirti Desai | CFO Director | Profile | |
| Susan MBA | Independent Officer | Profile | |
| Mittul Mehta | Chief Tevogenai | Profile | |
| Sadiq Khan | Chief Officer | Profile | |
| Jeffrey MPH | Member Officer | Profile | |
| Tapan Shah | Head Development | Profile | |
| Kirti CPA | Chief Officer | Profile | |
| Sadiq MBA | Chief Officer | Profile | |
| Neal MD | Global Officer | Profile | |
| Stephen MBA | Chief Officer | Profile |
About Tevogen Bio Management Performance
The success or failure of an entity such as Tevogen Bio Holdings often depends on how effective the management is. Tevogen Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tevogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tevogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.10 | 0.09 |
Please note, the imprecision that can be found in Tevogen Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tevogen Bio Holdings. Check Tevogen Bio's Beneish M Score to see the likelihood of Tevogen Bio's management manipulating its earnings.
Tevogen Bio Workforce Analysis
Traditionally, organizations such as Tevogen Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tevogen Bio within its industry.Tevogen Bio Manpower Efficiency
Return on Tevogen Bio Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 5.6K | |
| Net Loss Per Executive | 5.6K |
Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.